: Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say 0 10.11.2023 16:59 MarketWatch.com Company will halt development of experimental depression treatment Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
